Aim: This study was to evaluate in vitro anti-fungal activity of aqueous and hydroethanolic from medicinal plants extracts collected in Côte d'Ivoire. Materials and Methods: Plants extracts were prepared by homogenization and separately incorporated to Sabouraud agar using the agar slanted double dilution method. Ketoconazole was used as standards for anti-fungal assay. The anti-fungal tests were performed by sowing 1000 cells of Candida albicans on the previously prepared medium culture. Anti-fungal activity was determined by evaluating anti-fungal parameters values (minimal fungicidal concentrations [MFC] and IC50). Results: The results showed that all extracts possessed anti-fungal activities whose levels vary from plant species to another. Eight of them had a satisfactory anti-candidosic activity and extracts from Terminalia species were the most active. Among them the Terminalia superba extracts generated the strongest activities (MFC = 0.0975 mg/mL). Compared with ketoconazole (MFC = 0.390 mg/mL), the T. superba extracts, aqueous (MFC = 0.195 mg/mL) and hydroethanolic (0.0975 mg/mL) were successively twice and four times more active. The worst anti-fungal activity (MFC = 1600 mg/mL) was obtained with the Guarea cedrata aqueous extract. Conclusion: All medicinal plants extracts produced anti-fungal activities, and T. superba was the most active.
INTRODUCTION
At the end of an ethnobotanical survey conducted in 1991 in the area of Issia (Cote d'Ivoire) several medicinal plants were collected and identified by our research team. These plants are commonly used in traditional circles by the healers for their curative virtues. A large number of plants among the cataloged species are granted anti-infectious properties [1] . The in vitro anti-microbial properties of some plants have already been assessed by some members of our research team. This study was initiated to verify the anti-microbial virtues which some plants are granted in order to continue the studies initiated by our team. In this report, we summarize the results obtained after some in vitro tests with aqueous and hydroethanolic extracts from each plant against Candida albicans one of the most pathogenic fungi species to human. collected parts were the steam barks of the trees species and the whole aerial parts for the herbaceous species. The studied plants species are the following: In the first step of the study some samples of all the plants species were identified and taxonomically authenticated by professor Aké-Assi at the Herbarium of the floristic national center of the Felix Houphouët-Boigny University (Abidjan, Côte d'Ivoire). In the second step, some great quantities of plant parts of each species were collected separately. The parts were carefully checked to take out all undesired specimen parts. The parts were then cut into small fragments and carefully air-dried for 2 weeks at ambient temperature in the laboratory, under continuous ventilation, away from sunlight and dust. After that step all, the vegetal pieces were crushed to a fine powder with an electrical grinder. Finally, the different types of powder were hermetically sealed in polyethylene bags and stored away from light and moisture until the time of extraction.
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Extraction
Two sorts of extracts (aqueous and hydroethanolic) were prepared from the powder of each species. For the aqueous extract, 100 g of each type of powder were extracted in a solvent kept with 1 L of distilled water by homogenization in a blender. After six cycles of homogenization, the homogenates obtained were first wrung out in a fabric square and then filtered twice successively with absorbent cotton and once with Whatman 3 mm filter paper. The resulting filtrates were concentrated under vacuum using a Büchi rotary evaporator at 60°C [2] . Dark powder obtained is the aqueous crude extract. Hydroethanolic extracts were prepared following the same process by using a mixture of solvent ethanol 70% and water 30%.
Microorganism Studied
The tested fungi consist of a C. albicans (n 896/AB of 10.01.2000) clinical strain. It was both clinical isolate as well as authenticated and identified strain. This strain was provided by the Laboratory of Mycology of the Medical Sciences, Faculty of the Felix Houphouët-Boigny University (Abidjan Côte d'Ivoire).
C. albicans is an opportunistic fungus. It is a human normal communalist, and it belongs to the normal flora, but it becomes pathogenic when the immune system fails. It causes most of 83% of yeast infections [3, 4] . The generalized infection caused by this fungus in individuals severely immuno-compromised often leads to death [5] [6] [7] [8] [9] .
Anti-microbial Test
The anti-fungal activities were assessed by determining anti-fungal parameters values which are minimal fungicidal concentration (MFC); concentration that inhibits 99.99% of growth in the experimental tube compared with the growth control tube and concentration for 50% of inhibition (IC 50 ); graphically determined around each assay. For each extract, six replicate trials were conducted against C. albicans and ketoconazole was used as standards for anti-fungal assay. Ketoconazole was selected because it is an anti-fungal molecule usually prescribed to patients in the treatment of mycosis.
The anti-fungal tests were carried out on culture medium Sabouraud (Biomerieux, 51078 Ref: 777666501). The incorporation of plant extracts into the agar was made using the agar slanted double dilution method [2, [10] [11] [12] . After this, all 10 tubes of each series were sterilized in an autoclave at 121°C for 15 min and then inclined with a small base at room temperature to allow their cooling and solidification of the agar. Both aqueous and hydroethanolic extracts were tested separately.
Fungal germs culture on slanted agar previously prepared was made by sowing 1000 cells of C. albicans [11] . These cultures were incubated at 30°C for 48 h. At the end of the incubation time, colonies were counted out by direct counting with a colony counter pen (Ceinceware, number 23382). The growth in the 10 experimental tubes was expressed as survival percentage, calculated, compared to 100% of growth in the growth control tube. The formula to calculate this is shown below. For the test tubes, concentrations of plant extracts ranged from 1600 to 0.024375 mg/mL with a ½ reason geometrical connection.
The processing of these data permitted to calculate the MFC values. It also made it possible to plot the curves of activity of the extracts and the graphically determination of the IC 50 values.
Formula to calculate the survival percentage:
S: Survival (%) n: Number of colony in one experimental tube N: Number of colony in the growth control tube.
Activity Classification Scale
The anti-fungal activities of the plant extracts were classified into the category following the scale below. The activity scale is divided into five levels on the basis of the MFC values.
Activity Values
Very low activity MFC values>50 mg/mL Low activity MFC value=50 mg/mL Average activity 50 mg/mL>MFC values≥6.25 mg/mL High activity 6.25 mg/mL>MFC values≥0.780 mg/mL Very high activity 0.780 mg/mL>MFC values≥0.001526 mg/mL
RESULTS
The results were summarized in the form of curves of sensitivity and a table. The curves illustrate the evolution of the survival of C. albicans depending on the variation of the concentrations of the extracts [ Figures 1 and 2 ]. In general, all sensitivity curves showed a progressively decreasing pace with slopes that are stronger or not as strong according to the extracts. The curves whose slopes are strong illustrate high anti-fungal potency and those that have a weak slope reveal low anti-fungal potency. They intersect the horizontal axis at different levels according to the extracts. The slopes of the curves of the extracts from the Terminalia species are the strongest. While the weakest slopes are observed with curve of extracts from G. cedrata (BOSS) and E. cylindricum (ECYL) [ Figures 1 and 2 ]. The extracts from the other species have curves whose slopes are average. The decreasing shape of the activity curves shows that the 30 extracts acted according to a relation amount-effect. 
DISCUSSION
Analysis of the whole results shows that C. albicans are sensitive to all the extracts tested. The extracts were all capable of inhibiting the in vitro growth of the fungal germs. However, the levels of these anti-fungal activities are variable from one extract to another. As a matter of fact, the analysis of MFC values [ Table 1 ].
On the basis of the classification scale of the levels of the activities, the analysis of the data shows that among the aqueous extracts, nine plant species produced extracts whose MFC values range from 100 mg/mL to 1600 mg/mL. This led to classify them as plants whose extracts possess some very low levels of anti-fungal activities. These species are the following: C. pentandra, E. cylindricum, K. ivorensis, G. cedrata, M. excelsa, M. villosus, N. papaverifera, P. angulata, S. monostachyus. For this reason, these species are not recommended to treat anti-fungal infections in traditional circles. Unless an extraction method permitting a better concentration of their active principles as well as the improvement of their anti-fungal activities was applied.
The results also show that the aqueous extracts from E. angolense and H. eburnea have an MFC value of 50 mg/mL so they have a low activity level (Table 1 and anti-fungal activity classification scale). In addition, the aqueous extract TEKAM 3 -X Aq from T. catappa inhibited the growth of C. albicans with a MFC value of 0.780 mg/mL. According to the anti-fungal activity classification scale, its anti-candidosic activity is classified as a high level of activity. Finally, the other three Terminalia species generated extracts whose MFC value are respectively 0.39 mg/mL for T. ivorensis and T. mantaly, 0.195 mg/mL for T. superba. This led to catalogue them in the category of those that have a very high level of anti-fungal activity (Table 1 and activity classification scale).
Otherwise, the comparison with previous works shows that the aqueous extract they got from T. mantaly was four times more active on C. albicans [13] than the same kind of extract we tested in this study. The MFC value obtained in their study was 0.0975 mg/mL for the aqueous extracts TEKAM 1 -X Aq , while the MFC value is 0.390 mg/mL in this present study for the same type of extract. On the other hand, the comparison with works on T. superba [14] reveals that TEKAM 4 -X Aq (MFC = 0.195 mg/mL) is two times more active than the aqueous extract (MFC = 0.390 mg/mL) from T. superba tested by these authors. These differences of performance of these extracts could be explained by the fact that we did not collect the barks in the same area, and we did not test the extracts on the same C. albicans strain. The trees from which they collected the barks could contain low concentrations of active principles. And each fungal strain has its own sensitivity to anti-fungal drugs.
Meanwhile, the results from this study are in accordance with previous reports on the genus Terminalia, i.e. the works on T. ivorensis [15] and on T. catappa [16] . Because we obtained the same anti-fungal parameters values (MFC = 0.390 mg/mL and IC 50 = 0.054 mg/mL for T. ivorensis and MFC = 0.780 mg/mL and IC 50 = 0.523 mg/mL for T. catappa).
On the other hand, on the basis of MFC values, the comparison of the anti-fungal activities of all aqueous extracts shows that the aqueous extract from T. superba TEKAM 4 -X Aq (CMF = 0.195 mg/mL) is the most active of all. As a matter of fact, the MFC value ratios reveal that TEKAM 4 -X Aq is respectively two times more active than TEKAM 1 -X Aq (from T. mantaly) and TEKAM 2 -X Aq (T. ivorensis), it is also four times more active than TEKAM 3 -X Aq (T. catappa) and 256 times more active than ETAN-X Aq (E. angolense) and HUNT-X Aq (H. eburnea).
In addition, the anti-candidosic activity of TEKAM 4 -X Aq is 512 times stronger than that of EMI-X Aq (M. excelsa). TEKAM 4 -X Aq is also 1025 times more active than CEIBA-X Aq (C. pentandra), ACAJB-X Aq (K. ivorensis), PHYS-X Aq (P. angulata), MONOS-X Aq (S. monostachyus) and KOTIB-X Aq (N. papaverifera). Lastly TEKAM 4 -X Aq is respectively 2051 times and 8205 times more active than ECYL-X Aq (E. cylindricum) and BOSS-X Aq (G. cedrata).
For the hydroethanolic extracts, the comparison of their performances on the basis of the MFC values highlights that for this kind of extracts, the four Terminalia species once more resulted in the lowest value of MFC [ Otherwise, from the comparison of the whole data of the hydroethanolic extracts the result is that BOSS-X 0 (G. cedrata) that produced the highest MFC value of 800 mg/mL, is the least active of all. In fact, it is 16,410 times less active than TEKAM 4 -X 0 [ Table 1 ]. So eventually, among all aqueous and hydroethanolic extracts, the extracts from G. cedrata produced the lowest anti-candidosic activities because their MFC values were the highest of all. On the other hand, extracts from the four Terminalia species were the most active; because they generated the lowest MFC and IC 50 values against C. albicans. And particularly extracts from T. superba exhibited the best performances of all.
This strong anti-microbial potency of T. superba was also demonstrated by works on its methanolic extract which showed a broad spectrum of both anti-fungal and anti-bacterial activities [17] . This methanolic extract inhibited the in vitro growth of several strains of bacteria (Mycobacterium smegmatis, Mycobacterium tuberculosis, Staphylococcus aureus, Escherichia coli, Shigella dysenteriae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhi, Citrobacter freundii) and fungi (C. albicans, Candida glabrata, Microsporum audouinii, Trichophyton rubrum) [17] .
Finally, the comparison of the performances of all extracts tested with that of ketoconazole, reveals that this reference anti-fungal drug is more active than most of extracts tested excepted few extracts from Terminalia species. As a matter of fact, KETO is 256 times more active than MONOS-X 0 , PHYS-X 0 and ACAJB-X 0 ; 128 times more active than CEIBA-X 0 and KOTIB-X 0 ; 64 times more active than HUNT-X 0 and EMI-X 0 ; 32 times more active than ETAN-X 0 ; 16 times more active than MVS-X 0 . Ketoconazole is also twice more active than TEKAM 3 -X Aq . On the other hand, KETO produced the same MFC value (0.390 mg/mL) as TEKAM 1 -X Aq and TEKAM 2 -X Aq . However, on the basis of their IC 50 values, the comparison shows that Keto is respectively twice and three times more active than TEKAM 1 -X Aq and TEKAM 2 -X Aq .
However, compared with TEKAM 1 -X 0 , TEKAM 2 -X 0 , TEKAM 3 -X 0 and TEKAM 4 -X Aq on the basis of their MFC values, KETO is respectively two times less active than these extracts. Finally, on the same basis of this comparison, TEKAM 4 -X 0 (MFC = 0.0975 mg/mL), is clearly four times more active than ketoconazole [ Table 1 ].
On the whole, the obtained data from this study highlighted the significant anti-fungal potency of plants of Terminalia genus. Otherwise, several investigations on plants of the genus Terminalia have already been conducted by some research teams. And many results of these previous reports share the results from the present study concerning their anti-microbial activities. Indeed, these works also confirmed the strong anti-microbial activities of extracts from a number of Terminalia species such as T. catappa [16, 18, 19] , T. chebula [20] , T. glaucescens [21] , T. ivorensis [15, [22] [23] [24] , T. macroptera [25] , T. sericea [26, 27] , and T. superba [14, 17, 28] .
In addition, M. villosus was also reported for its broad spectrum of anti-fungal activities on C. albicans, C. glabrata, C. tropicalis and A. fumigatus, A. flavus, C. neoformans, T. rubrum and T. mentagrophytes [29] [30] [31] [32] . The comparison reveals that on C. albicans, the M. villosus extracts [30] produced the same MFC values as the present report. However, on the basis of their IC 50 values, they are two times less active than extracts from this study.
With other plant species, the comparison shows that TEKAM 4 -X Aq and TEKAM 4 -X 0 of T. superba are respectively 256 times and 125 times more active than aqueous extract and hydroethanolic extract from Microglossa pyrifolia tested on C. albicans [2] .
Moreover, the comparison of the whole data shows that for all plant species, hydroethanolic extracts are more active than the aqueous ones. As a matter of fact, for each case, hydroethanolic extracts produced MFC values that are 2-16 times lower than the MFC values of their aqueous equivalents [ Table 1 ] if one establishes a comparison between extracts from the same plant species. This shows that for all plant species, hydro-ethanolic extracts concentrate a greater proportion of active principles than their aqueous equivalents. This assertion is similar to former investigation reports [2, 13, 15, 16, [29] [30] [31] 33] . Indeed, the results of these previous investigations revealed that all the hydro-ethanolic extracts tested were 2-16 times more active than the equivalent aqueous extracts.
So we can deduce that between the two solvents used for extraction, the mixture ethanol-distilled water (70/30; v/v) is the solvent that permits the activity optimization and concentrates better the active principles from the different plants species. The active principles of all the plant species studied are more soluble in the mixture ethanol-distilled water (70/30; v/v). Considered under the chemical aspect, hydro-ethanolic extracts contain active principles that are of lipid nature and also polar molecules containing one or many oxygen atoms [2, 34] .
In addition, the active principles could be groups constituted by molecules of small sizes and average sizes (terpenoids, polyphenols, quinons, alkaloids, etc.) containing very low proportions of vegetal oil and chlorophyll [2, 33] . Even if water can extract all type of molecules, water extracts contain a great content of macromolecules (polysaccharids, proteins and glycoproteins). They also contain a few species of polar lipids of small size, whose structures are simples. This high proportion of polysaccharids, glycoproteins and proteins could explain why aqueous extracts are always less active.
Alternatively as regards this aspect, the analysis of the antifungal parameter values of 
ivorensis, T. mantaly, and T. superba).
The levels of their anti-fungal activities ranged from high to very high. Among them, the T. superba extracts generated the most excellent anti-candidosic activities. Furthermore, for each plant species, the hydroethanolic extracts were always noticeably 2-16 times as active as their equivalent aqueous.
Otherwise, the anti-fungal drug ketoconazole is clearly more active than most of extracts tested excepted TEKAM 1 -X 0 , TEKAM 2 -X 0 , TEKAM 3 -X 0 , TEKAM 4 -X Aq and TEKAM 4 -X 0 the extracts from the Terminalia species. In fact TEKAM 1 -X 0 , TEKAM 2 -X 0 , TEKAM 3 -X 0 and TEKAM 4 -X Aq are twice as active as ketoconazole; while TEKAM 4 -X 0 is four times as active. This study confirms the real and strong anti-fungal activities of extracts of extract from the Terminalia species. Among the two solvents used for the extractions, the mixture ethanoldistilled water (70/30; v/v) is the solvent that permits the best optimization of the extraction and concentration of the active principles from a different plant species.
It would be thus desirable to continue this work by investigating more the anti-fungal potency of extracts from the four Terminalia species. Specifically our further works will aim the search and the isolation of compounds responsible for the antifungal activities as well as the determination of the chemical structure of these active principles. Our team hopes that these investigations will help to isolate new active principles that may be used in human therapeutic or to isolate metabolites that could serve as templates for synthesizing new and more active molecules. These new molecules (natural or semi-synthetic) could then afford to expand the therapeutic arsenal and make it more effective.
